Gad Thomas

About Gad Thomas

Thomas Gad is the founder of Y-mAbs Therapeutics, which he established in April 2015, and he has served on the company’s Board of Directors since inception. He currently holds senior strategic responsibilities as Founder, Vice Chairman of the Board of Directors, and Chief Business Officer. His professional identity is closely tied to building Y-mAbs from the ground up, including helping secure executive leadership and initial seed capital for the company’s launch. He brings more than 12 years of experience in the pharmaceutical industry, with a background spanning business development, senior management, financing, and licensing negotiations. That experience has been particularly relevant to Y-mAbs’ development as a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based therapeutics. The company has emphasized innovative oncology programs, including work in pediatric cancer, and has aimed to address areas of significant unmet medical need. Gad’s decision to found Y-mAbs was deeply influenced by a personal family experience: his daughter’s difficult journey through high-risk neuroblastoma and her treatment with breakthrough immunotherapy at Memorial Sloan Kettering Cancer Center. That experience helped shape the company’s original mission and its long-term focus on novel cancer therapies. In his leadership role, Gad has been associated with the company’s strategic direction, including business development priorities, financing efforts, and partnership discussions. He earned a Bachelor of Science degree in Business Administration from Pepperdine University in California. Combining entrepreneurial initiative with life sciences business expertise, Gad has played a durable role in Y-mAbs’ governance and corporate strategy. His profile reflects a founder-led executive who has helped define both the commercial framework and the mission-driven identity of the organization.